Prostate Cancer: Quality of Life Related to Two Forms of Treatment

2.50
Hdl Handle:
http://hdl.handle.net/10755/149890
Type:
Presentation
Title:
Prostate Cancer: Quality of Life Related to Two Forms of Treatment
Abstract:
Prostate Cancer: Quality of Life Related to Two Forms of Treatment
Conference Sponsor:Sigma Theta Tau International
Conference Year:2005
Author:Ward-Smith, Peggy, RN, PhD
P.I. Institution Name:University of Missouri - Kansas City
Title:Assistant Professor
More than 229,900 men will be diagnosed with prostate cancer in the United States during 2004, making it the second leading cause of cancer death among men. Treatments for localized prostate cancer vary, from watchful waiting to radical surgery, with each treatment option demonstrating a similar survival curve. The purpose of these studies were to allow men, treated with either brachytherapy (BT) or conventional external beam radiation therapy (XRT), to self-evaluate their quality of life (QoL) before and 3, 6 and 12 months after treatment. A 39-item, Likert scale QoL instrument specifically developed for this population was used for data collection (FACT-P). Data from the 59 men in each treatment group were analyzed by t-test, ANOVA and Least Significant Difference Post-Hoc testing. Those treated with XRT demonstrated statistically significance changes in the FACT-P subscales of physical, social and specific prostate concerns over the 12 months. Those treated with BT demonstrated statistically significance changes in the physical and specific prostate concerns sub-scales 3 months after treatment. Awareness of how each treatment impacts self-evaluated QoL will assist nurses when providing education to those making treatment choices.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleProstate Cancer: Quality of Life Related to Two Forms of Treatmenten_GB
dc.identifier.urihttp://hdl.handle.net/10755/149890-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Prostate Cancer: Quality of Life Related to Two Forms of Treatment</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2005</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Ward-Smith, Peggy, RN, PhD</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">University of Missouri - Kansas City</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Assistant Professor</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">wardsmithp@umkc.edu</td></tr><tr><td colspan="2" class="item-abstract">More than 229,900 men will be diagnosed with prostate cancer in the United States during 2004, making it the second leading cause of cancer death among men. Treatments for localized prostate cancer vary, from watchful waiting to radical surgery, with each treatment option demonstrating a similar survival curve. The purpose of these studies were to allow men, treated with either brachytherapy (BT) or conventional external beam radiation therapy (XRT), to self-evaluate their quality of life (QoL) before and 3, 6 and 12 months after treatment. A 39-item, Likert scale QoL instrument specifically developed for this population was used for data collection (FACT-P). Data from the 59 men in each treatment group were analyzed by t-test, ANOVA and Least Significant Difference Post-Hoc testing. Those treated with XRT demonstrated statistically significance changes in the FACT-P subscales of physical, social and specific prostate concerns over the 12 months. Those treated with BT demonstrated statistically significance changes in the physical and specific prostate concerns sub-scales 3 months after treatment. Awareness of how each treatment impacts self-evaluated QoL will assist nurses when providing education to those making treatment choices.</td></tr></table>en_GB
dc.date.available2011-10-26T10:11:50Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T10:11:50Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.